Biomarker analysis on breast ductal lavage cells in women with and without breast cancer

International Journal of Cancer

Volumn 119, Issue 2, 2006, Pages 359-364

  Zhang, Wei ^a   Yang, Yu Ching ^b   Zhang, Bao Ning ^a   Pan, Qin Jing ^a   Hart, Steven D ^c   Duvall, Karen ^c   Zhang, Zuo Feng ^b   Rao, Jian Yu ^b,c  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Cellular biomarker; Ductal lavage; G actin

Indexed keywords

DNA 5C EXCEEDING RATE; G ACTIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST DISEASE; BREAST DUCT; BREAST PAPILLOMA; CANCER DIAGNOSIS; CANCER RISK; CHINESE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LASER SCANNING CYTOMETRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ACTINS; ADULT; AGED; BIOLOGICAL MARKERS; BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHINA; CYTODIAGNOSIS; DNA, NEOPLASM; ESTROGENS, CONJUGATED (USP); FEASIBILITY STUDIES; FEMALE; HUMANS; IRRIGATION; LASER SCANNING CYTOMETRY; MAMMARY GLANDS, HUMAN; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33745218354     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21854     Document Type: Article

References (22)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8-29.
2. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389-99.
3. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997;71:800-9.
4. Wellings SR. A hypothesis of the origin of human breast cancer from the terminal ductal lobular unit. Pathol Res Pract 1980;166:515-35.
5. Wellings SR, Jensen HM, Marcum RG. Atlas of subgross pathology of human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975;55:231-73.
6. Love SM, Barsky SH. Breast-duct endoscopy to study stages of cancerous breast disease. Lancet 1996;348:997-9.
7. Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O'Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Phillips RF, Ganz PA, Euhus DM, et al. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 2001;93:1624-32.
8. Khan SA, Wiley EL, Rodriguez N, Baird C, Ramakrishnan R, Nayar R, Bryk M, Bethke KB, Staradub VL, Wolfman J, Rademaker A, Ljung BM, et al. Ductal lavage findings in women with known breast cancer undergoing mastectomy. J Natl Cancer Inst 2004;96:1510-7.
9. Rao JY, Bonner RB, Hurst RE, Liang YY, Reznikoff CA, Hemstreet GP, III. Quantitative changes in cytoskeletal and nuclear actins during cellular transformation. Int J Cancer 1997;70:423-9.
10. Rao JY, Hemstreet GP, III, Hurst RE, Bonner RB, Min KW, Jones PL. Cellular F-actin levels as a marker for cellular transformation: correlation with bladder cancer risk. Cancer Res 1991;51:2762-7.
11. Rao JY, Hurst RE, Bales WD, Jones PL, Bass RA, Archer LT, Bell PB, Hemstreet GP, III. Cellular F-actin levels as a marker for cellular transformation: relationship to cell division and differentiation. Cancer Res 1990;50:2215-20.
12. Hemstreet GP, III, Bonner RB, Hurst RE, Bell D, Bane BL. Abnormal G-actin content in single prostate cells as a biomarker of prostate cancer. Cancer Detect Prev 2000;24:464-72.
13. Hemstreet GP, III, Rao J, Hurst RE, Bonner RB, Mellott JE, Rooker GM. Biomarkers in monitoring for efficacy of immunotherapy and chemoprevention of bladder cancer with dimethylsulfoxide. Cancer Detect Prev 1999;23:163-71.
14. Rao JY, Hemstreet GP, III, Hurst RE, Bonner RB, Jones PL, Min KW, Fradet Y. Alterations in pnenotypic biochemical markers in bladder epithelium during tumorigenesis. Proc Natl Acad Sci USA 1993;90:8287-91.
15. Hemstreet GP, III, Rao JY, Hurst RE, Bonner RB, Jones PL, Vaidya AM, Fradet Y, Moon RC, Kelloff GJ. Intermediate endpoint biomarkers for chemoprevention. J Cell Biochem 1992;16 (Suppl. I):93-110.
16. Rao JY, Apple SK, Hemstreet GP, Jin Y, Nieberg RK. Single cell multiple biomarker analysis in archival breast fine-needle aspiration specimens: quantitative fluorescence image analysis of DNA content, p53, and G-actin as breast cancer biomarkers. Cancer Epidemiol Biomarkers Prev 1998;7:1027-33.
17. NIH Consensus Development Conference. The uniform approach to breast fine-needle aspiration biopsy. Am J Surg 1997;174:371-85.
18. Badve S, Wiley E, Rodriguez N. Assessment of utility of ductal lavage and ductoscopy in breast cancer-a retrospective analysis of mastectomy specimens. Mod Pathol 2003;16:206-9.
19. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953;6:963-8.
20. Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst 1998;90:1198-205.
21. Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Ljung B, Davidson NE, Sukumar S. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet 2001;357:1335-6.
22. King BL, Tsai SC, Gryga ME, D'Aquila TG, Seelig SA, Morrison LE, Jacobson KK, Legator MS, Ward DC, Rimm DL, Phillips RF. Detection of chromosomal instability in paired breast surgery and ductal lavage specimens by interphase fluorescence in situ hybridization. Clin Cancer Res 2003;9:1509-16.